Target intelligence / Profile preview

Mucosal and systemic immune system

Molecular classification
Other
01

Overview

The mucosal and systemic immune systems represent the integrated network of lymphoid tissues and cells responsible for host defense. The mucosal immune system is the largest component, protecting barrier surfaces like the gastrointestinal and respiratory tracts through specialized structures like Peyer's patches and the production of secretory IgA (Brandtzaeg, P. 'Mucosal immunity: induction, effector functions, and control', 2011). The systemic immune system, centered in the spleen and lymph nodes, provides internal surveillance and responds to pathogens that have entered the bloodstream or tissues (Mowat, A. M., & Agace, W. W. 'Regional specialization of the mucosal immune system', 2014). These systems are functionally linked but maintain distinct regulatory mechanisms to prevent overreaction to harmless antigens while ensuring robust responses to pathogens. Because this term describes a complex physiological system rather than a single protein or receptor, it is not classified as a specific therapeutic target in drug discovery (Janeway, C. A. Jr, et al. 'Immunobiology: The Immune System in Health and Disease', 2001).

Other names
Mucosal immunitySystemic immunityHost immune systemIntegrated immune systemMucosa-associated lymphoid tissue (MALT)Secondary lymphoid organs
02

Mechanism of action

Broad immunomodulation including cytokine inhibition, lymphocyte depletion, blockade of costimulatory signals, and checkpoint inhibition.

03

Biological functions

Immune responseHost defenseInflammationHomeostasisLeukocyte traffickingPathogen clearance
04

Disease associations

InfectionAutoimmune diseaseInflammatory bowel diseaseCancerAllergyAsthma
05

Safety considerations

Opportunistic infectionsReactivation of latent tuberculosisSecondary malignancyCytokine release syndromeImmune-related adverse events (irAEs)
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Secretory IgA (sIgA)Fecal calprotectinInterleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Mucosal and systemic immune system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucosal and systemic immune system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call